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ABSTRACT
Background. No consensus between guidelines exists regarding neuroimaging in first-
episode psychosis. The purpose of this study is to assess anomalies found in structural
neuroimaging exams (brain computed tomography (CT) and magnetic resonance
imaging (MRI)) in the initial medical work-up of patients presenting first-episode
psychosis.
Methods. The study subjects were 32 patients aged 18–48 years (mean age: 29.6 years),
consecutively admitted with first-episode psychosis diagnosis. Socio-demographic and
clinical data and neuroimaging exams (CT and MRI) were retrospectively studied.
Diagnostic assessments were made using the Operational Criteria Checklist +. Neu-
roimaging images (CT andMRI) and respective reportswere analysed by an experienced
consultant psychiatrist.
Results. None of the patients had abnormalities in neuroimaging exams responsible
for psychotic symptoms. Thirty-seven percent of patients had incidental brain findings
not causally related to the psychosis (brain atrophy, arachnoid cyst, asymmetric lateral
ventricles, dilated lateral ventricles, plagiocephaly and falx cerebri calcification). No
further medical referral was needed for any of these patients. No significant differences
regarding gender, age, diagnosis, duration of untreated psychosis, in-stay and cannabis
use were found between patients who had neuroimaging abnormalities versus those
without.
Discussion. This study suggests that structural neuroimaging exams reveal scarce
abnormalities in young patients with first-episode psychosis. Structural neuroimaging
is especially useful in first-episode psychosis patients with neurological symptoms,
atypical clinical picture and old age.
Subjects Neurology, Psychiatry and Psychology, Radiology and Medical Imaging
Keywords First-episode psychosis, Neuroimaging, Magnetic resonance imaging, Brain computed
tomography
INTRODUCTION
Frequently, structural neuroimaging exams (brain computed tomography (CT) and
magnetic resonance imaging (MRI)) are requested as part of the initial medical work-up in
young patients with first-episode psychosis (Freudenreich, Schulz & Goff , 2009). The aim
is to exclude ‘‘organic’’ brain causes that could explain psychotic symptoms and modify
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Table 1 Some current guidelines regarding neuroimaging in first-episode psychosis.
National Institute for Health
and Clinical Excellence (2008)
American Psychiatric Associa-
tion (2006)
Canadian Psychiatric Associa-
tion (2005)
Royal Australian and New
Zealand College of Psychiatrists
2005 (McGorry, 2005)
‘‘Structural neuroimaging tech-
niques (either magnetic reso-
nance imaging (MRI) or com-
puted axial tomography (CT)
scanning) are not recommended
as a routine part of the initial in-
vestigations for the management
of first-episode psychosis.’’
‘‘A CT or MRI scan may provide
helpful information, particularly
in assessing patients with a new
onset of psychosis or with an
atypical clinical presentation.’’
‘‘Excluding patients with head
injury, neurologic disease,
seizures, or substance abuse,
7.9% of MRI scans obtained
in first-episode patients were
of ‘‘clinical importance,
affecting prognosis, diagnosis, or
management.’’
Baseline MRI scan should be
done as part of optimal initial
assessment in first-episode psy-
chosis.
‘‘. . . this decision should not af-
fect the current practice of using
structural neuroimaging tech-
niques selectively to exclude or-
ganic causes of psychosis where
people’s symptoms, or other as-
pects of their presentation, sug-
gest a higher likelihood of an un-
derlying organic cause.’’
‘‘Recommends CT or MRI in
baseline assessment of first-
episode psychosis.’’
management and treatment (Woolley, 2005). These include brain injury, demyelinating
disease, tumours, multiple sclerosis or stroke. In recent years, much research has been
made in both structural and functional neuroimaging in early phases of psychosis (Dazzan
et al., 2015; Hager & Keshavan, 2015; Jardri, 2013; Jung et al., 2010; Strakowski et al., 2008;
Tognin et al., 2014). However, the impact of these studies in clinical practice has been
disappointing.
Guidelines are divergent regarding neuroimaging in first-episode psychosis. Table 1
summarises some of the current major guidelines (American Psychiatric Association, 2006;
Canadian Psychiatric Association, 2005; McGorry, 2005; National Institute for Health and
Clinical Excellence, 2008). When admitting young patients with first-episode psychosis with
no positive neurological findings, physicians are faced with the decision if brain imaging
should be performed. Early identification of ‘‘organic’’ lesions responsible for psychotic
symptoms could lead to a change in the treatment because the lesions may be surgically or
medically treatable. Initial reports seemed promising, with abnormality rates of 30%, but
with time most of these findings in structural neuroimaging were incidental and not causal
to the psychotic picture (Goodstein, 1985;Weinberger, 1984).
Published studies show rates of overall structural neuroimaging abnormalities between
0% and 65.2% in patients with first-episode psychosis. Incidental unrelated to the psychosis
structural neuroimaging abnormalities are found between 2.4% and 65.2% of patients and
neuroimaging abnormalities link to psychosis in 0%–2.7% (Bain, 1998; Battaglia & Spector,
1988; Gewirtz et al., 1994; Khandanpour, Hoggard & Connolly, 2013; Lubman et al., 2002;
Robert Williams, Yukio Koyanagi & Shigemi Hishinuma, 2014). Most of researches only
studied CT neuroimaging (Battaglia & Spector, 1988; Bain, 1998;Gewirtz et al., 1994; Strahl,
Cheung & Stuckey, 2010), one included only MRI neuroimaging (Lubman et al., 2002) and
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three studies included CT and MRI neuroimaging (Goulet et al., 2009; Khandanpour,
Hoggard & Connolly, 2013; Robert Williams, Yukio Koyanagi & Shigemi Hishinuma, 2014).
Therefore, divergent results in structural neuroimaging abnormalities rates could bemainly
explained by different patient age included. As expected, studies where older patients with
first-episode psychosis were included more neuroimaging abnormalities were found. For
example Gewirtz et al. (1994) studied first-episode psychosis patients with a mean age of
35, ranging between 18 and 66 years. CT neuroimaging was studied and 42.3% revealed
benign and nonspecific abnormalities (diffuse cortical atrophy, arachnoid cysts, ventricular
enlargement and venous angioma) and 2.4% of abnormalities link to psychosis (arachnoid
cyst in right temporal area, bilateral parietal and subinsular infarcts, bilateral parietal
ischemic changes and colloidal cyst in the third ventricule with obstrutction of the foramen
of Munro) (Gewirtz et al., 1994). By the contrary in one published study that included only
young first-episode psychosis patients (age between 12 and 30 years) (Robert Williams,
Yukio Koyanagi & Shigemi Hishinuma, 2014) revealed 5.2% of incidental neuroimaging
findings with none considered to be causal to psychosis. When included only the few
studies published with young first-episode psychosis patients, overall non causal structural
neuroimaging abnormalities results revealed rates from 2.2% to 13.2%, and abnormalities
link to psychosis from 0% to 1.3% (Bain, 1998; Goulet et al., 2009; Lubman et al., 2002;
Robert Williams, Yukio Koyanagi & Shigemi Hishinuma, 2014).
CT andMRI are the most used structural neuroimaging techniques in daily clinical prac-
tice. CT scans are assessable and take little time, but deliver radiation. MRI carries no risk of
radiation exposure, provides better spatial resolution and grey-white matter differentiation
than CT. MRI is not widely available mainly because of the cost compared with CT. MRI
is particularly useful in epilepsy, multiple sclerosis, small brain tumours and vasculitis.
The aim of this study is to evaluate abnormalities found in neuroimaging exams in a
sample of young patients with first-episode psychosis. Complementing the few studies
published, we try to contribute to more robust evidence-based decisions about structural
neuroimaging in clinical practice in young first-episode psychosis patients. We also tried to
overcome existing limitations of previous published studies, including only patients with
first-episode psychosis diagnosis, young patients (age < 50 years), consecutive patient series
and referred all details of study design. We included as well CT and MRI neuroimaging
and in- and outpatients approaching to daily clinical routine.
MATERIALS AND METHODS
Sample
The sample included consecutive, non-affective, first-episode psychosis patients, presenting
to theDepartment of Psychiatry ofHospital Vila Franca deXira, Portugal, fromAugust 2013
to September 2015. Hospital Vila Franca de Xira is a general hospital in the metropolitan
area of Lisbon, Portugal, with a population of 245,000. Psychosis was defined according
DSM-IV criteria (American Psychiatric Association, 1994). Inclusion criteria were an
individual experiencing his or her non-affective first-episode psychosis, aged 16–48 years
and living in the area of Hospital Vila Franca de Xira. The study was approved by Hospital
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Vila Franca de Xira Ethics Committee. In addition to the written informed consent to
the brain imaging that all patients give during the daily routine of neuroimaging, each
participant gave a specific written informed consent to the present study.
Data collection
The medical electronic files of the patients were reviewed retrospectively. Socio-
demographic and clinical data, neuroimaging images (CT and MRI) and respective reports
were analysed by an experienced consultant psychiatrist. CT scans were performed in
Siemens SOMATON Emotion 16 CT machine with 2.4 mm section thickness (Siemens
Healthcare). All CT studies were considered for contrast administration after review
of non-contrasted study. In 12 patients contrast for contrast-enhanced CT scan was
administered. MRI were performed in Toshiba Titan 1.5 T machine (Toshiba Medical
Systems Europe). All participants evaluated using MRI had sagittal T1-weighted, axial
T2-weighted, axial T2-weighted Flair, axial gradient-echo, axial diffusion-weighted and
coronal T2-weighted imaging. Gadolinium-enhanced MRI was used in all MRI studies
performed (axial, sagittal and T1-weighted coronal sequences). CT and MRI images were
analyzed using Impax 6.5. Software (Agfa Healthcare Inc.). All CT and MRI reports had
been written by a consultant neuroradiologist. When a doubt persisted after examination
of the neuroimaging images and reports, collaboration of a consultant neuroradiologist
was used to reanalyse the exams. Brain images (CT and/or MRI) are used in daily practice
in the clinical evaluation of all first-episode psychosis presenting to the Department of
Psychiatry as part of the initialmedical work-up. Patientswith only non-brain abnormalities
in CT scan or MRI (sinus disease, sebaceous cyst or dermoid cyst) were included in
patients without neuroimaging abnormalities. We used the Operational Criteria Checklist
+ (OPCRIT+) instrument to achieve DSM-IV diagnosis (McGuffin, Farmer & Harvey,
1991; Rucker et al., 2011). OPCRIT+ is a checklist including items of psychiatric history
and psychopathology. Checklist ratings are entered into the OPCRIT+ software, which
generates a diagnosis for the main categories of affective and psychotic disorders defined
according to major classification systems, including DSM-IV. OPCRIT+ has been shown to
have good reliability when used by different raters. The rater was an experienced consultant
psychiatrist, trained in the use of OPCRIT+.
Statistical analysis
Statistical analysis wasmade using SPSS statistics 21 forWindows (SPSS, Chicago, IL, USA).
Descriptive analyses are presented as proportions for count data and asmeans with standard
deviations (SD) for continuous data. We separated the samples in two groups, according
to the existence of neuroimaging abnormalities (i.e., with vs. without neuroimaging
abnormalities), and compared some socio-demographic and clinical characteristics using
chi-squared test for categorical variables (or Fisher exact tests as appropriate) and student’s
t -test for continuous variables. The level of statistical significance was p< 0.05.
RESULTS
There were a total of 32 patients who met the inclusion criteria (male = 59.4%). The mean
age was 29.6 years (SD = 8.7), ranging from 18 to 48 years. A total of 65.6% were single,
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18.8%married and 15.6% divorced. Twenty-two percent of the participants were students,
53.13% unemployed and 25% employed. Of the sample, 6.3% participants lived alone.
There was cannabis use in 53.13% of the participants, and 65.63% had an in-stay during
acute phase of the illness. Mean duration of untreated psychosis (DUP) was 76.5 weeks
(SD = 107.4). According to DSM-IV diagnosis, 31.25% had the diagnosis of schizophrenia,
40.63% psychotic disorder not otherwise specified, 21.88% cannabis-induced psychotic
disorder and 6.25% delusional disorder. All patients were on first days of antipsychotic
medication when CT scan or MRI was performed. Regarding the type of medication,
31.25% patients were treated with risperidone oral, 21.88% with olanzapine oral, 15.63%
paliperidone palmitate long-acting injectable, 9.38% aripiprazole oral, 9.38% paliperidone
oral, 6.25%haloperidol oral, 3.13% risperidone long-acting injectable and 3.13%quetiapine
fumarate extended-release oral.
Twenty-nine (90.63%) patients received a CT, 1 (3.13%) anMRI and 2 (6.25%) both CT
andMRI. None of the neuroimaging findings was considered to be a potential or significant
contributory cause to the psychotic episode. Twelve patients (37.5%) had incidental brain
lesions not causally related to the psychosis: brain atrophy (n= 4), arachnoid cyst (n= 3),
asymmetric lateral ventricles (n= 2), dilated lateral ventricles (n= 1), plagiocephaly (n= 1)
and falx cerebri calcification (n= 1).
There were no statistically significant differences between participants groups (with
vs. without neuroimaging abnormalities) regarding gender (p= 0.687), age (p= 0.490),
DUP (p= 0.399), psychiatric diagnosis (p= 0.069), in-stay (p= 0.582) and cannabis use
(p= 0.108) (Table 2).
DISCUSSION
In our sample, no neuroimaging lesions responsible for psychotic symptoms were found.
Minor incidental abnormalities were present in 37.5% of the patients. Despite the relevant
methodological differences compared to previous published studies, our results are in
line with other studies that included young patients in first-episode psychosis. In 1998,
Battaglia & Spector studied 45 patients with first-episode psychosis who received a CT
scan, and three scans showed positive findings that correlated with neuropsychiatric
symptomatology (Battaglia & Spector, 1988). Goulet et al. (2009) studied 46 patients with
first-episode psychosis, in which 44 had CT scans, two had MRI and only one patient
showed a lipoma above the pineal gland with no relation with clinical picture. Like our
research, previous published studies show that findings in structural brain imaging in
young patients with first-episode psychosis are limited regarding clinical utility.
Contrary to our sample in which only young people with first-episode psychosis were
included, the mentioned study published by Khandanpour, Hoggard & Connolly (2013)
included first-episode psychosis ranging between 16 and 95 years, including MRI and
CT scans. Among patients who underwent MRI, 2.7% had brain lesions potentially
responsible for the psychosis (brain tumour, meningioma and human immunodeficiency
virus encephalopathy), and 62.5% had incidental brain lesions. Among patients who had
CT scans, 1.5% had focal brain lesions potentially accountable for the psychosis, and 65.2%
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Table 2 Socio-demographic and clinical characteristics of patients with and without neuroimaging
abnormalities.
Patients with
neuroimaging
abnormalities n= 11
Patients without
neuroimaging
abnormalities n= 21
P-value
;Gender
; Male 6 13 NS
; Female 5 8
;Age
; Mean years (SD) 28.09 (9.40) 30.38 (8.49) NS
;Diagnosis DSM-IV
; Schizophrenia 2 8
; Delusional disorder 2 0 NS
; Cannabis induced 4 3
; Psychotic disorder
; Psychotic disorder not 3 10
; Otherwise specified
;DUP
; Mean weeks (SD) 53.92 (58.55) 88.27 (125.48) NS
;In-stay (n) 7 14 NS
;Cannabis use 8 9 NS
Notes.
NS, not significant; SD, standard deviation; DSM-IV, Diagnostic and Statistical of Mental Disorders, fourth edition; DUP,
duration of untreated psychosis.
had incidental brain lesions not responsible to the psychosis. These results seem to indicate
that in older (>50 years) first-episode psychotic patients, structural neuroimaging exams
identify a higher number of organic lesions responsible for the psychosis, even so in low rate.
As expected, we did not find any significant differences between the group of patients
with incidental brain findings and those without, reflecting that these neuroimaging
findings do not reflect a subgroup of patients with particular socio-demographic or clinical
characteristics (e.g., longer DUP or more in-stay) (Table 2).
None of the studies chose patients randomly, including our own. But contrary to most
of published studies, we include patients consecutively, reducing selection bias.
Only one study that specifically investigated economical factors of structural neuroimag-
ing in psychosis was found (Albon et al., 2008). The authors concluded that if screening
with structural neuroimaging was implemented in all patients presenting with psychotic
symptoms before 65 years, little would be found to affect clinical management. The authors
also emphasised that there is a paucity in good-quality evidence on the clinical benefits of
structural neuroimaging on which to base economic research; thus, the outcome from an
economic perspective is not clear.
Our study has some limitations. First, our sample is limited in size, which can limit
generalisation of the findings. However, we think it is representative, and our results are
similar to other studies in which larger samples were included. Second, we did not include
a control group (patients without first-episode psychosis) and therefore did not compare
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prevalence and type of the radiological findings. Third, few patients included had an
MRI, but taking into account previous studies, this would likely not significantly alter our
findings.
CONCLUSIONS
In conclusion, our results are concordant with the few previous studies in which clinically
relevant abnormalities in structural neuroimaging in young patients with first-episode
psychosis are scarce. We think that neurological examination is a valuable adjunct
instrument once it can help to determine if a patient has signs of a brain lesion, so
structural neuroimaging should be performed. However, sometimes the psychiatric status
did not permit the elaboration of a good-quality neurological examination, so it would
be desirable to improve clinical status first and after doing a neurological examination.
Neuroimaging exams should specially be performed in some clinical pictures, such as in
patients with neurological symptoms or signs, atypical clinical picture, delirium/organic
suggestive symptoms (visual hallucinations, disorientation, memory loss and blurred
conscience) and old age (age > 50 years). When a neuroimaging exam is indicated, an MRI
should probably be performed because of previously mentioned advantages. MRI should
be especially preferred if epilepsy, multiple sclerosis, small tumours and vasculitis are major
diagnostic hypotheses.
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